.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Federal Trade Commission
AstraZeneca
Healthtrust
QuintilesIMS
Teva
McKesson
Novartis
Harvard Business School
Julphar

Generated: September 26, 2017

DrugPatentWatch Database Preview

AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% Drug Profile

« Back to Dashboard

What is the patent landscape for Aminophylline In Sodium Chloride 0.45%, and when can generic versions of Aminophylline In Sodium Chloride 0.45% launch?

Aminophylline In Sodium Chloride 0.45% is a drug marketed by Hospira and is included in two NDAs.

The generic ingredient in AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% is aminophylline. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aminophylline profile page.

Summary for Tradename: AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%

Patents:0
Applicants:1
NDAs:2
Bulk Api Vendors: see list47
Clinical Trials: see list2,614
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%
aminophylline
INJECTABLE;INJECTION088147-002May 3, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
aminophylline
INJECTABLE;INJECTION018924-002Dec 12, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
AMINOPHYLLINE IN SODIUM CHLORIDE 0.45%
aminophylline
INJECTABLE;INJECTION088147-003May 3, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
aminophylline
INJECTABLE;INJECTION018924-001Dec 12, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
aminophylline
INJECTABLE;INJECTION018924-004Dec 12, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
AMINOPHYLLINE IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER
aminophylline
INJECTABLE;INJECTION018924-003Dec 12, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Accenture
QuintilesIMS
Baxter
Citi
Argus Health
Farmers Insurance
Merck
US Department of Justice
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot